This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Concerned InfuSystem Stockholders Announce Favorable ISS Recommendation

Meson Capital Partners, LLC, Boston Avenue Capital, LLC and the Global Undervalued Securities Master Fund, LP (the “Concerned InfuSystem Stockholders”) announce that on February 28, 2012, ISS—the nation’s leading independent proxy advisory firm—recommended that its clients consent on the WHITE card to call a special meeting of InfuSystem stockholders. ISS’ analyses are followed by hundreds of major institutional investment firms, mutual and pension funds and other fiduciaries.

The Concerned InfuSystem Stockholders also announce that as of February 29, 2012, it had submitted agent designations on behalf of 11,699,426, or 54.85%, of the Company’s total outstanding shares to the Company to call a special meeting with the purpose of changing the entire board of directors. The Concerned InfuSystem Stockholders thank stockholders for their participation and support in this first step of a two-step democratic process.

“We believe this strong stockholder support for the special meeting to replace the board indicates that holders of a majority of the Company’s shares lack confidence in the Company’s current board and its ability to reflect such holders’ interests,” said Ryan Morris, Managing Member of Meson Capital. “We urge stockholders to resist the Company’s attempts to divert stockholders’ attention and not to revoke their consents to call a special meeting. We believe it is clearer than ever that a timely full and fair election is necessary to ensure that the best interests of the stockholders are appropriately represented. We welcome the special meeting at the earliest possible date.”

The Definitive Proxy Statement of the Concerned InfuSystem Stockholders' Solicitation to call a Special Meeting of Stockholders is publicly available at no charge through the website of the Securities and Exchange Commission at http://www.sec.gov. The Definitive Proxy Statement was mailed to stockholders on or about February 2, 2012.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs